Atlanta, GA, United States of America

David Gaul

This inventor holds 1 USPTO granted patent. Top assignee: Georgia Tech Research Corporation. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Gaul. Retrieved from https://idiyas.com/inventor/david-gaul-bnxgh6ax

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of David Gaul

Introduction

David Gaul is an accomplished inventor based in Atlanta, GA. He has made significant strides in the field of medical technology, particularly in the detection and treatment of ovarian cancer. His innovative approach has the potential to change the way early-stage serous ovarian cancer is diagnosed.

Latest Patents

David Gaul holds a patent for a groundbreaking method in the detection of early-stage serous ovarian cancer. This method utilizes up to sixteen compounds found in the blood serum of individuals. By analyzing changes in these compounds, the method can determine the presence of serous ovarian cancer in women with up to 100% accuracy, specificity, and sensitivity. This patent represents a significant advancement in cancer diagnostics.

Career Highlights

David Gaul is affiliated with the Georgia Tech Research Corporation, where he continues to work on innovative solutions in medical technology. His dedication to research and development has positioned him as a key figure in the fight against ovarian cancer.

Collaborations

David has collaborated with notable colleagues, including Facundo Martin Fernandez and John Francis McDonald. Their combined expertise enhances the research efforts at Georgia Tech Research Corporation.

Conclusion

David Gaul's contributions to the field of cancer detection exemplify the impact of innovation in medical technology. His work not only advances scientific understanding but also holds promise for improving patient outcomes in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…